Search

Displaying results 7641 - 7650 of 10000 in total
  1. Drug

    Premazepam

    go.drugbank.com/drugs/DB21027
    Experimental

    Premazepam is a small molecule drug. The usage of the INN stem '-azepam' in the name indicates that Premazepam is a diazepam derivative. Premazepam has a monoisotopic molecular weight of 253.12 Da.

  2. Drug

    Elfazepam

    go.drugbank.com/drugs/DB21142
    Experimental

    Elfazepam is a small molecule drug. The usage of the INN stem '-azepam' in the name indicates that Elfazepam is a diazepam derivative. Elfazepam has a monoisotopic molecular weight of 408.07 Da.

  3. Drug

    Maroxepin

    go.drugbank.com/drugs/DB21379
    Experimental

    Maroxepin is a small molecule drug. The usage of the INN stem '-oxepin' in the name indicates that Maroxepin is a tricyclic compound. Maroxepin has a monoisotopic molecular weight of 277.15 Da.

  4. Drug

    Reclazepam

    go.drugbank.com/drugs/DB21411
    Experimental

    Reclazepam is a small molecule drug. The usage of the INN stem '-azepam' in the name indicates that Reclazepam is a diazepam derivative. Reclazepam has a monoisotopic molecular weight of 373.04 Da.

  5. Drug

    Metoxepin

    go.drugbank.com/drugs/DB21433
    Experimental

    Metoxepin is a small molecule drug. The usage of the INN stem '-oxepin' in the name indicates that Metoxepin is a tricyclic compound. Metoxepin has a monoisotopic molecular weight of 322.17 Da.

  6. Drug

    Davelizomib

    go.drugbank.com/drugs/DB21660
    Experimental

    Davelizomib is a small molecule drug. The usage of the INN stem '-zomib' in the name indicates that Davelizomib is a proteasome inhibitor. Davelizomib has a monoisotopic molecular weight of 481.18 Da.

  7. Drug

    Virginiamycin M1

    go.drugbank.com/drugs/DB01669
    Experimental

    Pristinamycin IIA is a macrolide antibiotic, a member of the streptogramin A group of antibiotics, and one component of pristinamycin. It is produced by Streptomyces graminofaciens and other bacteria.

  8. Drug

    Covax-19™

    go.drugbank.com/drugs/DB15846
    Investigational

    As of June 2020, the vaccine is in Phase 1 trials to evaluate safety and immune responses (NCT04428073). … Phase 2 and 3 trials are planned for September 2020, and the vaccine is expected to launch early in 2021.

  9. Drug

    Bleomycin A6

    go.drugbank.com/drugs/DB12992
    Investigational

    Bleomycin A6 (also known as boanmycin) has been used in trials studying the treatment of Squamous Cell Lung Cancer. It was developed in China as an antineoplastic antibiotic. … This drug participated in clinical trials for the treatment of Squamous Cell Lung Cancer.

  10. Drug

    Protionamide

    go.drugbank.com/drugs/DB12667
    ApprovedInvestigationalWithdrawn

    Prothionamide has been used in trials studying the treatment of MDR-TB and HIV Infections.